Keeping up NF-κB appearances: Epigenetic control of immunity or inflammation-triggered epigenetics

Biochemical Pharmacology

Volumn 72, Issue 9 SPEC. ISS., 2006, Pages 1114-1131

  Vanden Berghe, Wim ^a   Ndlovu, 'Matladi N ^a   Hoya Arias, Ruben ^a   Dijsselbloem, Nathalie ^a   Gerlo, Sarah ^a   Haegeman, Guy ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Chromatin; Cofactor; DNA methylation; Epigenetics; Histone; NF B

Indexed keywords

B LYMPHOCYTE RECEPTOR; DNA; ENHANCEOSOME; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; DNA BINDING; DYNAMICS; EPIGENETICS; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; IMMUNITY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL;

EID: 33749051214     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.07.012     Document Type: Article

References (417)

1. Hayden M.S., and Ghosh S. Signaling to NF-kappaB. Genes Dev 18 18 (2004) 2195-2224
2. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5 10 (2005) 749-759
3. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3 1 (2004) 17-26
4. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25 6 (2004) 280-288
5. Bellavia D., Campese A.F., Alesse E., Vacca A., Felli M.P., Balestri A., et al. Constitutive activation of NF-kappaB and T-cell leukemia/lymphoma in Notch3 transgenic mice. EMBO J 19 13 (2000) 3337-3348
6. Vacca A., Felli M.P., Palermo R., Di Mario G., Calce A., Di Giovine M., et al. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukaemia. EMBO J 25 5 (2006) 1000-1008
7. Shin H.M., Minter L.M., Cho O.H., Gottipati S., Fauq A.H., Golde T.E., et al. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 25 1 (2006) 129-138
8. Perkins N.D., and Gilmore T.D. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ 13 5 (2006) 759-772
9. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., et al. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293 5534 (2001) 1495-1499
10. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., et al. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17 4 (2002) 525-535
11. Hyatt G., Melamed R., Park R., Seguritan R., Laplace C., Poirot L., et al. Gene expression microarrays: glimpses of the immunological genome. Nat Immunol 7 7 (2006) 686-691
12. O'Donnell S.M., Holm G.H., Pierce J.M., Tian B., Watson M.J., Chari R.S., et al. Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus. J Virol 80 3 (2006) 1077-1086
13. Tian B., and Brasier A.R. Identification of a nuclear factor kappa B-dependent gene network. Recent Prog Horm Res 58 (2003) 95-130
14. Tian B., Nowak D.E., Jamaluddin M., Wang S., and Brasier A.R. Identification of direct genomic targets downstream of the nuclear factor-kappaB transcription factor mediating tumor necrosis factor signalling. J Biol Chem 280 17 (2005) 17435-17448
15. Tian B., Nowak D.E., and Brasier A.R. A TNF-induced gene expression program under oscillatory NF-kappaB control. BMC Genomics 6 (2005) 137
16. Shaffer A.L., Rosenwald A., Hurt E.M., Giltnane J.M., Lam L.T., Pickeral O.K., et al. Signatures of the immune response. Immunity 15 3 (2001) 375-385
17. Werner S.L., Barken D., and Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309 5742 (2005) 1857-1861
18. Covert M.W., Leung T.H., Gaston J.E., and Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 309 5742 (2005) 1854-1857
19. Nelson D.E., Ihekwaba A.E., Elliott M., Johnson J.R., Gibney C.A., Foreman B.E., et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science 306 5696 (2004) 704-708
20. Hoffmann A., Levchenko A., Scott M.L., and Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298 5596 (2002) 1241-1245
21. Barken D., Wang C.J., Kearns J., Cheong R., Hoffmann A., and Levchenko A. Comment on "oscillations in NF-kappaB signaling control the dynamics of gene expression". Science 308 5718 (2005) 52 [author reply 52]
22. Cheong R., Bergmann A., Werner S.L., Regal J., Hoffmann A., and Levchenko A. Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses. J Biol Chem 281 5 (2006) 2945-2950
23. Lipniacki T., Paszek P., Brasier A.R., Luxon B.A., and Kimmel M. Stochastic regulation in early immune response. Biophys J 90 3 (2006) 725-742
24. Janes K.A., Gaudet S., Albeck J.G., Nielsen U.B., Lauffenburger D.A., and Sorger P.K. The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell 124 6 (2006) 1225-1239
25. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3 9 (2003) 745-756
26. Kawai T, Akira S. TLR signaling. Cell Death Differ 2006.
27. Rawlings D.J. The biology and biochemistry of inflammatory signalosomes. Meeting on signaling networks in immunity and inflammation. EMBO Rep 7 1 (2006) 25-30
28. Hoffmann A., and Baltimore D. Circuitry of nuclear factor kappaB signalling. Immunol Rev 210 (2006) 171-186
29. Kholodenko B.N. Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol 7 3 (2006) 165-176
30. Bouwmeester T., Bauch A., Ruffner H., Angrand P.O., Bergamini G., Croughton K., et al. A physical and functional map of the human TNF-alpha/NF-kappaB signal transduction pathway. Nat Cell Biol 6 2 (2004) 97-105
31. Bauch A., and Superti-Furga G. Charting protein complexes, signaling pathways, and networks in the immune system. Immunol Rev 210 (2006) 187-207
32. Swart G.W. Cell 'guidling'. EMBO Rep 7 4 (2006) 348-351
33. Shaffer A.L., and Staudt L.M. Genomics and proteomics: reduce, rebuild, reveal. Immunol Rev 210 (2006) 5-7
34. Foley E., and O'Farrell P.H. Functional dissection of an innate immune response by a genome-wide RNAi screen. PLoS Biol 2 8 (2004) E203
35. Perez O.D., and Nolan G.P. Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunol Rev 210 (2006) 208-228
36. Pasparakis M., Luedde T., and Schmidt-Supprian M. Dissection of the NF-kappaB signalling cascade in transgenic and knockout mice. Cell Death Differ 13 5 (2006) 861-872
37. Schreiber J., Jenner R.G., Murray H.L., Gerber G.K., Gifford D.K., and Young R.A. Coordinated binding of NF-{kappa}B family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci USA 103 15 (2006) 5899-5904
38. Natoli G., and De Santa F. Shaping alternative NF-kappaB-dependent gene expression programs: new clues to specificity. Cell Death Differ 13 5 (2006) 693-696
39. Udalova I.A., Mott R., Field D., and Kwiatkowski D. Quantitative prediction of NF-kappa B DNA-protein interactions. Proc Natl Acad Sci USA 99 12 (2002) 8167-8172
40. Linnell J., Mott R., Field S., Kwiatkowski D.P., Ragoussis J., and Udalova I.A. Quantitative high-throughput analysis of transcription factor binding specificities. Nucl Acids Res 32 4 (2004) e44
41. Saccani S., Pantano S., and Natoli G. Modulation of NF-kappaB activity by exchange of dimers. Mol Cell 11 6 (2003) 1563-1574
42. Lefstin J.A., and Yamamoto K.R. Allosteric effects of DNA on transcriptional regulators. Nature 392 6679 (1998) 885-888
43. Hoffmann A., Leung T.H., and Baltimore D. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J 22 20 (2003) 5530-5539
44. Vermeulen L., De Wilde G., Notebaert S., Vanden Berghe W., and Haegeman G. Regulation of the transcriptional activity of the nuclear factor-kappaB p65 subunit. Biochem Pharmacol 64 5-6 (2002) 963-970
45. Viatour P., Merville M.P., Bours V., and Chariot A. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30 1 (2005) 43-52
46. Chen L.F., Williams S.A., Mu Y., Nakano H., Duerr J.M., Buckbinder L., et al. NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 25 18 (2005) 7966-7975
47. Jacque E., Tchenio T., Piton G., Romeo P.H., and Baud V. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc Natl Acad Sci USA 102 41 (2005) 14635-14640
48. Stark L.A., and Dunlop M.G. Nucleolar sequestration of RelA (p65) regulates NF-kappaB-driven transcription and apoptosis. Mol Cell Biol 25 14 (2005) 5985-6004
49. Jiang J., and Levine M. Binding affinities and cooperative interactions with bHLH activators delimit threshold responses to the dorsal gradient morphogen. Cell 72 5 (1993) 741-752
50. Schaaf M.J., Willetts L., Hayes B.P., Maschera B., Stylianou E., and Farrow S.N. The relationship between intranuclear mobility of the NF-{kappa}B subunit p65 and its DNA binding affinity. J Biol Chem 281 31 (2006) 22409-22420
51. Merika M., and Thanos D. Enhanceosomes. Curr Opin Genet Dev 11 2 (2001) 205-208
52. Vanden Berghe W., De Bosscher K., Boone E., Plaisance S., and Haegeman G. The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem 274 45 (1999) 32091-32098
53. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., et al. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem 273 6 (1998) 3285-3290
54. Merika M., Williams A.J., Chen G., Collins T., and Thanos D. Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription. Mol Cell 1 2 (1998) 277-287
55. Thanos D., and Maniatis T. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83 7 (1995) 1091-1100
56. Senger K., Armstrong G.W., Rowell W.J., Kwan J.M., Markstein M., and Levine M. Immunity regulatory DNAs share common organizational features in Drosophila. Mol Cell 13 1 (2004) 19-32
57. Hallikas O., Palin K., Sinjushina N., Rautiainen R., Partanen J., Ukkonen E., et al. Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell 124 1 (2006) 47-59
58. Smale S.T. Core promoters: active contributors to combinatorial gene regulation. Genes Dev 15 19 (2001) 2503-2508
59. Edelstein L.C., Lagos L., Simmons M., Tirumalai H., and Gelinas C. NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1. Mol Cell Biol 23 8 (2003) 2749-2761
60. Park J.M., Greten F.R., Wong A., Westrick R.J., Arthur J.S., Otsu K., et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaB as key regulators. Immunity 23 3 (2005) 319-329
61. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., et al. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122 5 (2005) 707-721
62. Krappmann D., Wegener E., Sunami Y., Esen M., Thiel A., Mordmuller B., et al. The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1. Mol Cell Biol 24 14 (2004) 6488-6500
63. Kim T., Yoon J., Cho H., Lee W.B., Kim J., Song Y.H., et al. Downregulation of lipopolysaccharide response in Drosophila by negative crosstalk between the AP1 and NF-kappaB signaling modules. Nat Immunol 6 2 (2005) 211-218
64. Moscat J., Rennert P., and Diaz-Meco M.T. PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways. Cell Death Differ 13 5 (2006) 702-711
65. Wang T., Lafuse W.P., and Zwilling B.S. NFkappaB and Sp1 elements are necessary for maximal transcription of Toll-like receptor 2 induced by Mycobacterium avium. J Immunol 167 12 (2001) 6924-6932
66. Cakouros D., Cockerill P.N., Bert A.G., Mital R., Roberts D.C., and Shannon M.F. A NF-kappa B/Sp1 region is essential for chromatin remodeling and correct transcription of a human granulocyte-macrophage colony-stimulating factor transgene. J Immunol 167 1 (2001) 302-310
67. Plevy S.E., Gemberling J.H., Hsu S., Dorner A.J., and Smale S.T. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol Cell Biol 17 8 (1997) 4572-4588
68. Benoit V., Hellin A.C., Huygen S., Gielen J., Bours V., and Merville M.P. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter. Oncogene 19 41 (2000) 4787-4794
69. Plaisance S., Vanden Berghe W., Boone E., Fiers W., and Haegeman G. Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol Cell Biol 17 7 (1997) 3733-3743
70. Agresti A., and Bianchi M.E. HMGB proteins and gene expression. Curr Opin Genet Dev 13 2 (2003) 170-178
71. Bianchi M.E., and Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr Opin Genet Dev 15 5 (2005) 496-506
72. Falvo J.V., Uglialoro A.M., Brinkman B.M., Merika M., Parekh B.S., Tsai E.Y., et al. Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol Cell Biol 20 6 (2000) 2239-2247
73. Sanceau J., Kaisho T., Hirano T., and Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J Biol Chem 270 46 (1995) 27920-27931
74. Himes S.R., Coles L.S., Reeves R., and Shannon M.F. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. Immunity 5 5 (1996) 479-489
75. Grosschedl R., Giese K., and Pagel J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet 10 3 (1994) 94-100
76. Brickman J.M., Adam M., and Ptashne M. Interactions between an HMG-1 protein and members of the Rel family. Proc Natl Acad Sci USA 96 19 (1999) 10679-10683
77. Perrella M.A., Pellacani A., Wiesel P., Chin M.T., Foster L.C., Ibanez M., et al. High mobility group-I(Y) protein facilitates nuclear factor-kappaB binding and transactivation of the inducible nitric-oxide synthase promoter/enhancer. J Biol Chem 274 13 (1999) 9045-9052
78. Yie J., Merika M., Munshi N., Chen G., and Thanos D. The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome. EMBO J 18 11 (1999) 3074-3089
79. Zhang X.M., and Verdine G.L. A small region in HMG I(Y) is critical for cooperation with NF-kappaB on DNA. J Biol Chem 274 29 (1999) 20235-20243
80. Minami T., and Aird W.C. Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-kappa B and GATA motifs. J Biol Chem 276 50 (2001) 47632-47641
81. Kadalayil L., Petersen U.M., and Engstrom Y. Adjacent GATA and kappa B-like motifs regulate the expression of a Drosophila immune gene. Nucl Acids Res 25 6 (1997) 1233-1239
82. Petersen U.M., Kadalayil L., Rehorn K.P., Hoshizaki D.K., Reuter R., and Engstrom Y. Serpent regulates Drosophila immunity genes in the larval fat body through an essential GATA motif. EMBO J 18 14 (1999) 4013-4022
83. Papi A., and Johnston S.L. Respiratory epithelial cell expression of vascular cell adhesion molecule-1 and its up-regulation by rhinovirus infection via NF-kappaB and GATA transcription factors. J Biol Chem 274 42 (1999) 30041-30051
84. Ise R., Han D., Takahashi Y., Terasaka S., Inoue A., Tanji M., et al. Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Lett 579 7 (2005) 1732-1740
85. Gilchrist M., Thorsson V., Li B., Rust A.G., Korb M., Kennedy K., et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441 7090 (2006) 173-178
86. Zwergal A., Quirling M., Saugel B., Huth K.C., Sydlik C., Poli V., et al. C/EBPbeta blocks p65 phosphorylation and thereby NF-{kappa}B-mediated transcription in TNF-tolerant cells. J Immunol 177 1 (2006) 665-672
87. Rosenfeld M.G., Lunyak V.V., and Glass C.K. Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20 11 (2006) 1405-1428
88. Reid G., Hubner M.R., Métivier R., Brand H., Denger S., Manu D., et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11 3 (2003) 695-707
89. Métivier R., Penot G., Hubner M.R., Reid G., Brand H., Kos M., et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 6 (2003) 751-763
90. Perissi V., and Rosenfeld M.G. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 6 7 (2005) 542-554
91. Baek S.H., Ohgi K.A., Rose D.W., Koo E.H., Glass C.K., and Rosenfeld M.G. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110 1 (2002) 55-67
92. Zhong H., May M.J., Jimi E., and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9 3 (2002) 625-636
93. Saccani S., Marazzi I., Beg A.A., and Natoli G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response. J Exp Med 200 1 (2004) 107-113
94. Vermeulen L., De Wilde G., Damme P.V., Vanden Berghe W., and Haegeman G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22 6 (2003) 1313-1324
95. Vanden Berghe W., De Bosscher K., Vermeulen L., De Wilde G., and Haegeman G. Induction and repression of NF-kB-driven inflammatory genes. Ernst Schering Res Found Workshop 40 (2002) 233-278
96. Glass C.K., and Ogawa S. Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 6 1 (2006) 44-55
97. Cosma M.P. Ordered recruitment: gene-specific mechanism of transcription activation. Mol Cell 10 2 (2002) 227-236
98. Lin Y.S., Carey M., Ptashne M., and Green M.R. How different eukaryotic transcriptional activators can cooperate promiscuously. Nature 345 6273 (1990) 359-361
99. Métivier R., Reid G., and Gannon F. Transcription in four dimensions: nuclear receptor-directed initiation of gene expression. EMBO Rep 7 2 (2006) 161-167
100. Bosisio D., Marazzi I., Agresti A., Shimizu N., Bianchi M., and Natoli G. A hyper-dynamic equilibrium between promoter-bound and nucleoplasmid dimers controls NF-kB-dependent gene activity. EMBO J 25 (2006) 798-810
101. Voss T.C., John S., and Hager G.L. Single cell analysis of glucocorticoid receptor action reveals that stochastic post-chromatin association mechanisms regulate ligand-specific transcription. Mol Endocrinol (2006)
102. Arias A.M., and Hayward P. Filtering transcriptional noise during development: concepts and mechanisms. Nat Rev Genet 7 1 (2006) 34-44
103. Natoli G. Tuning up inflammation: how DNA sequence and chromatin organization control the induction of inflammatory genes by NF-kappaB. FEBS Lett 12 (2006) 2843-2849
104. Schreiber S.L., and Bernstein B.E. Signaling network model of chromatin. Cell 111 6 (2002) 771-778
105. Espinosa L., Ingles-Esteve J., Robert-Moreno A., and Bigas A. IkappaBalpha and p65 regulate the cytoplasmic shuttling of nuclear corepressors: cross-talk between Notch and NFkappaB pathways. Mol Biol Cell 14 2 (2003) 491-502
106. Aguilera C., Hoya-Arias R., Haegeman G., Espinosa L., and Bigas A. Recruitment of IkappaBalpha to the hes1 promoter is associated with transcriptional repression. Proc Natl Acad Sci USA 101 47 (2004) 16537-16542
107. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23 12 (2004) 2369-2380
108. Hoberg J.E., Yeung F., and Mayo M.W. SMRT derepression by the IkappaB kinase alpha: a prerequisite to NF-kappaB transcription and survival. Mol Cell 16 2 (2004) 245-255
109. Hoberg J.E., Popko A.E., Ramsey C.S., and Mayo M.W. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol 26 2 (2006) 457-471
110. Hirotani T., Lee P.Y., Kuwata H., Yamamoto M., Matsumoto M., Kawase I., et al. The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria. J Immunol 174 6 (2005) 3650-3657
111. Yamamoto M., Yamazaki S., Uematsu S., Sato S., Hemmi H., Hoshino K., et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430 6996 (2004) 218-222
112. Wu R.C., Qin J., Hashimoto Y., Wong J., Xu J., Tsai S.Y., et al. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase. Mol Cell Biol 22 10 (2002) 3549-3561
113. Wu R.C., Qin J., Yi P., Wong J., Tsai S.Y., Tsai M.J., et al. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol Cell 15 6 (2004) 937-949
114. Torchia J., Glass C., and Rosenfeld M.G. Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol 10 3 (1998) 373-383
115. Sheppard K.A., Rose D.W., Haque Z.K., Kurokawa R., McInerney E., Westin S., et al. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol Cell Biol 19 9 (1999) 6367-6378
116. Rosenfeld M.G., and Glass C.K. Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276 40 (2001) 36865-36868
117. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 Suppl (2002) S81-S96
118. Chen L.F., and Greene W.C. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5 5 (2004) 392-401
119. Schmitz M.L., Bacher S., and Kracht M. I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem Sci 26 3 (2001) 186-190
120. Natoli G., Saccani S., Bosisio D., and Marazzi I. Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6 5 (2005) 439-445
121. Fischle W., Wang Y., and Allis C.D. Histone and chromatin cross-talk. Curr Opin Cell Biol 15 2 (2003) 172-183
122. Teferedegne B., Green M.R., Guo Z., and Boss J.M. Mechanism of action of a distal NF-kappaB-dependent enhancer. Mol Cell Biol 26 15 (2006) 5759-5770
123. Egger G., Liang G., Aparicio A., and Jones P.A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429 6990 (2004) 457-463
124. Henikoff S., Furuyama T., and Ahmad K. Histone variants, nucleosome assembly and epigenetic inheritance. Trends Genet 20 7 (2004) 320-326
125. Fuks F. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 15 5 (2005) 490-495
126. Smale S.T., and Fisher A.G. Chromatin structure and gene regulation in the immune system. Annu Rev Immunol 20 (2002) 427-462
127. Holloway A.F., Rao S., and Shannon M.F. Regulation of cytokine gene transcription in the immune system. Mol Immunol 38 8 (2002) 567-580
128. Wang Y., Fischle W., Cheung W., Jacobs S., Khorasanizadeh S., and Allis C.D. Beyond the double helix: writing and reading the histone code. Novartis Found Symp 259 (2004) 3-17 [discussion 17-21, 163-9]
129. Fischle W., Wang Y., and Allis C.D. Binary switches and modification cassettes in histone biology and beyond. Nature 425 6957 (2003) 475-479
130. Hake S.B., and Allis C.D. Histone H3 variants and their potential role in indexing mammalian genomes: the "H3 barcode hypothesis". Proc Natl Acad Sci USA 103 17 (2006) 6428-6435
131. Pokholok D.K., Harbison C.T., Levine S., Cole M., Hannett N.M., Lee T.I., et al. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122 4 (2005) 517-527
132. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 5532 (2001) 1074-1080
133. Strahl B.D., and Allis C.D. The language of covalent histone modifications. Nature 403 6765 (2000) 41-45
134. Henikoff S. Histone modifications: combinatorial complexity or cumulative simplicity?. Proc Natl Acad Sci USA 102 15 (2005) 5308-5309
135. Margueron R., Trojer P., and Reinberg D. The key to development: interpreting the histone code?. Curr Opin Genet Dev 15 2 (2005) 163-176
136. Turner B.M. Reading signals on the nucleosome with a new nomenclature for modified histones. Nat Struct Mol Biol 12 2 (2005) 110-112
137. Turner B.M. Is it a code: the debate. Scientist 20 5 (2006) 34-41
138. Seet B.T., Dikic I., Zhou M.M., and Pawson T. Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol 7 7 (2006) 473-483
139. Liu C.L., Kaplan T., Kim M., Buratowski S., Schreiber S.L., Friedman N., et al. Single-nucleosome mapping of histone modifications in S. cerevisiae. PLoS Biol 3 10 (2005) e328
140. Reinke H., Gregory P.D., and Horz W. A transient histone hyperacetylation signal marks nucleosomes for remodeling at the PHO8 promoter in vivo. Mol Cell 7 3 (2001) 529-538
141. Clayton A.L., Hazzalin C.A., and Mahadevan L.C. Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell 23 3 (2006) 289-296
142. Cosgrove M.S., Boeke J.D., and Wolberger C. Regulated nucleosome mobility and the histone code. Nat Struct Mol Biol 11 11 (2004) 1037-1043
143. Lee C.K., Shibata Y., Rao B., Strahl B.D., and Lieb J.D. Evidence for nucleosome depletion at active regulatory regions genome-wide. Nat Genet 36 8 (2004) 900-905
144. Kireeva M.L., Walter W., Tchernajenko V., Bondarenko V., Kashlev M., and Studitsky V.M. Nucleosome remodeling induced by RNA polymerase II: loss of the H2A/H2B dimer during transcription. Mol Cell 9 3 (2002) 541-552
145. Gunjan A., Paik J., and Verreault A. The emergence of regulated histone proteolysis. Curr Opin Genet Dev 16 2 (2006) 112-118
146. Boix-Chornet M., Fraga M.F., Villar-Garea A., Caballero R., Espada J., Nunez A., et al. Release of hypoacetylated and trimethylated histone H4 is an epigenetic marker of early apoptosis. J Biol Chem 281 19 (2006) 13540-13547
147. Workman J.L. Nucleosome displacement in transcription. Genes Dev 20 15 (2006) 2009-2017
148. Mito Y., Henikoff J.G., and Henikoff S. Genome-scale profiling of histone H3.3 replacement patterns. Nat Genet 37 10 (2005) 1090-1097
149. Angelov D., Molla A., Perche P.Y., Hans F., Cote J., Khochbin S., et al. The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling. Mol Cell 11 4 (2003) 1033-1041
150. Li B., Pattenden S.G., Lee D., Gutierrez J., Chen J., Seidel C., et al. Preferential occupancy of histone variant H2AZ at inactive promoters influences local histone modifications and chromatin remodelling. Proc Natl Acad Sci USA 102 51 (2005) 18385-18390
151. Farris S.D., Rubio E.D., Moon J.J., Gombert W.M., Nelson B.H., and Krumm A. Transcription-induced chromatin remodeling at the c-myc gene involves the local exchange of histone H2A.Z. J Biol Chem 280 26 (2005) 25298-25303
152. Morimoto R. Dynamic remodeling of transcription complexes by molecular chaperones. Cell 110 3 (2002) 281
153. Freeman B.C., and Yamamoto K.R. Continuous recycling: a mechanism for modulatory signal transduction. Trends Biochem Sci 26 5 (2001) 285-290
154. Freeman B.C., and Yamamoto K.R. Disassembly of transcriptional regulatory complexes by molecular chaperones. Science 296 5576 (2002) 2232-2235
155. Agalioti T., Chen G., and Thanos D. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111 3 (2002) 381-392
156. Ramirez-Carrozzi V., Nazarian A., Sarah C., Gore L., Sridharan R., Imbalzano A., et al. Selective and antagonistic functions of SWI/SNF and Mi-2[beta] nucleosome remodeling complexes during an inflammatory response. Genes Dev 20 3 (2006) 286-296
157. Saha A., Wittmeyer J., and Cairns B.R. Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol 7 6 (2006) 437-447
158. Turner B.M. Cellular memory and the histone code. Cell 111 3 (2002) 285-291
159. Nightingale K.P., O'Neill L.P., and Turner B.M. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr Opin Genet Dev 16 2 (2006) 125-136
160. Benecke A. Chromatin code, local non-equilibrium dynamics, and the emergence of transcription regulatory programs. Eur Phys J E Soft Matter 19 3 (2006) 353-366
161. Lesne A. The chromatin regulatory code: beyond a histone code. Eur Phys J E Soft Matter 19 3 (2006) 375-377
162. Zhou J., and Berger S.L. Good fences make good neighbors: barrier elements and genomic regulation. Mol Cell 16 4 (2004) 500-502
163. Drissen R., Palstra R.J., Gillemans N., Splinter E., Grosveld F., Philipsen S., et al. The active spatial organization of the beta-globin locus requires the transcription factor EKLF. Genes Dev 18 20 (2004) 2485-2490
164. de Laat W., and Grosveld F. Spatial organization of gene expression: the active chromatin hub. Chromosome Res 11 5 (2003) 447-459
165. Chakalova L., Debrand E., Mitchell J.A., Osborne C.S., and Fraser P. Replication and transcription: shaping the landscape of the genome. Nat Rev Genet 6 9 (2005) 669-677
166. Sproul D., Gilbert N., and Bickmore W.A. The role of chromatin structure in regulating the expression of clustered genes. Nat Rev Genet 6 10 (2005) 775-781
167. Zink D., Fischer A.H., and Nickerson J.A. Nuclear structure in cancer cells. Nat Rev Cancer 4 9 (2004) 677-687
168. Lamond A.I., and Spector D.L. Nuclear speckles: a model for nuclear organelles. Nat Rev Mol Cell Biol 4 8 (2003) 605-612
169. Kosak S.T., Skok J.A., Medina K.L., Riblet R., Le Beau M.M., Fisher A.G., et al. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296 5565 (2002) 158-162
170. Guccione E., Martinato F., Finocchiaro G., Luzi L., Tizzoni L., Dall' Olio V., et al. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 8 7 (2006) 764-770
171. Li Q., and Wrange O. Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning. Mol Cell Biol 15 8 (1995) 4375-4384
172. Li Q., and Wrange O. Translational positioning of a nucleosomal glucocorticoid response element modulates glucocorticoid receptor affinity. Genes Dev 7 12A (1993) 2471-2482
173. Lomvardas S., and Thanos D. Modifying gene expression programs by altering core promoter chromatin architecture. Cell 110 2 (2002) 261-271
174. Beato M., and Eisfeld K. Transcription factor access to chromatin. Nucl Acids Res 25 18 (1997) 3559-3563
175. Saccani S., Pantano S., and Natoli G. Two waves of nuclear factor kappaB recruitment to target promoters. J Exp Med 193 12 (2001) 1351-1359
176. Saccani S., Pantano S., and Natoli G. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol 3 1 (2002) 69-75
177. Anest V., Hanson J., Cogswell P., Steinbrecher K., Strahl B., and Baldwin A. A nucleosomal function for IκB kinase-a in NF-κB-dependent gene expression. Nature 423 (2003) 659-663
178. Vanden Berghe W., Dijsselbloem N., Vermeulen L., Ndlovu N., Boone E., and Haegeman G. Attenuation of mitogen- and stress-activated protein kinase-1-driven nuclear factor-{kappa}B gene expression by soy isoflavones does not require estrogenic activity. Cancer Res 66 9 (2006) 4852-4862
179. Saccani S., and Natoli G. Dynamic changes in histone H3 Lys 9 methylation occurring at tightly regulated inducible inflammatory genes. Genes Dev 16 17 (2002) 2219-2224
180. Park GY, Wang X, Hu N, Pedchenko TV, Blackwell TS, Christman JW. NIK is involved in nucleosomal regulation by enhancing histone H3 phosphorylation by IKKalpha. J Biol Chem 2006.
181. Hassa P.O., Haenni S.S., Buerki C., Meier N.I., Lane W.S., Owen H., et al. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J Biol Chem 280 49 (2005) 40450-40464
182. Hassa P.O., Buerki C., Lombardi C., Imhof R., and Hottiger M.O. Transcriptional coactivation of nuclear factor-kappaB-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J Biol Chem 278 46 (2003) 45145-45153
183. Covic M., Hassa P.O., Saccani S., Buerki C., Meier N.I., Lombardi C., et al. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J 24 1 (2005) 85-96
184. Miao F., Li S., Chavez V., Lanting L., and Natarajan R. CARM1 enhances NF-{kappa}B mediated gene transcription through methylation of histone H3 at arginine 17. Mol Endocrinol 20 (2006) 1562-1573
185. Ganesh L., Yoshimoto T., Moorthy N., Akahata W., Boehm M., Nabel E., et al. Protein methyltransferase 2 inhibits NF-{kappa}B function and promotes apoptosis. Mol Cell Biol 26 (2006) 3864-3874
186. Ryo A., Suizu F., Yoshida Y., Perrem K., Liou Y.C., Wulf G., et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol Cell 12 6 (2003) 1413-1426
187. Ashburner B.P., Westerheide S.D., and Baldwin Jr. A.S. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21 20 (2001) 7065-7077
188. Burkhart B.A., Hebbar P.B., Trotter K.W., and Archer T.K. Chromatin-dependent E1A activity modulates NF-kappaB RelA-mediated repression of glucocorticoid receptor-dependent transcription. J Biol Chem 280 8 (2005) 6349-6358
189. Holloway A.F., Rao S., Chen X., and Shannon M.F. Changes in chromatin accessibility across the GM-CSF promoter upon T cell activation are dependent on nuclear factor kappaB proteins. J Exp Med 197 4 (2003) 413-423
190. Mérienne K., Pannetier S., Harel-Bellan A., and Sassone-Corsi P. Mitogen-regulated RSK2-CBP interaction controls their kinase and acetylase activities. Mol Cell Biol 21 20 (2001) 7089-7096
191. Fischle W., Dequiedt F., Fillion M., Hendzel M.J., Voelter W., and Verdin E. Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J Biol Chem 276 38 (2001) 35826-35835
192. Liu Y., Randall W.R., and Schneider M.F. Activity-dependent and -independent nuclear fluxes of HDAC4 mediated by different kinases in adult skeletal muscle. J Cell Biol 168 6 (2005) 887-897
193. Chawla S., Vanhoutte P., Arnold F.J., Huang C.L., and Bading H. Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J Neurochem 85 1 (2003) 151-159
194. Kao H.Y., Verdel A., Tsai C.C., Simon C., Juguilon H., and Khochbin S. Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7. J Biol Chem 276 50 (2001) 47496-47507
195. Wang A.H., and Yang X.J. Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol Cell Biol 21 17 (2001) 5992-6005
196. Zhao X., Ito A., Kane C.D., Liao T.S., Bolger T.A., Lemrow S.M., et al. The modular nature of histone deacetylase HDAC4 confers phosphorylation-dependent intracellular trafficking. J Biol Chem 276 37 (2001) 35042-35048
197. Agresti A., Scaffidi P., Riva A., Caiolfa V.R., and Bianchi M.E. GR and HMGB1 interact only within chromatin and influence each other's residence time. Mol Cell 18 1 (2005) 109-121
198. Ghersa P., Whelan J., Cambet Y., DeLamarter J.F., and Hooft van Huijsduijnen R. Distamycin prolongs E-selectin expression by interacting with a specific NF-kappaB-HMG-I(Y) binding site in the promoter. Nucl Acids Res 25 2 (1997) 339-346
199. Mattout A., Dechat T., Adam S.A., Goldman R.D., and Gruenbaum Y. Nuclear lamins, diseases and aging. Curr Opin Cell Biol 18 (2006) 335-341
200. Hutchison C.J. Lamins: building blocks or regulators of gene expression?. Nat Rev Mol Cell Biol 3 11 (2002) 848-858
201. Mendjan S., Taipale M., Kind J., Holz H., Gebhardt P., Schelder M., et al. Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila. Mol Cell 21 6 (2006) 811-823
202. Akhtar A., and Matera A.G. In and around the nucleus. Nat Cell Biol 8 1 (2006) 3-6
203. Somech R., Shaklai S., Geller O., Amariglio N., Simon A.J., Rechavi G., et al. The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation. J Cell Sci 118 Pt 17 (2005) 4017-4025
204. Ragoczy T., Bender M.A., Telling A., Byron R., and Groudine M. The locus control region is required for association of the murine beta-globin locus with engaged transcription factories during erythroid maturation. Genes Dev 20 11 (2006) 1447-1457
205. Vieu E., and Hernandez N. Actin's latest act: polymerizing to facilitate transcription?. Nat Cell Biol 8 7 (2006) 650-651
206. Wu X., Yoo Y., Okuhama N.N., Tucker P.W., Liu G., and Guan J.L. Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its nuclear-binding partners. Nat Cell Biol 8 7 (2006) 756-763
207. Szerlong H., Saha A., and Cairns B.R. The nuclear actin-related proteins Arp7 and Arp9: a dimeric module that cooperates with architectural proteins for chromatin remodelling. EMBO J 22 12 (2003) 3175-3187
208. Hinsby A.M., Kiemer L., Karlberg E.O., Lage K., Fausboll A., Juncker A.S., et al. A wiring of the human nucleolus. Mol Cell 22 2 (2006) 285-295
209. Shuai K., and Liu B. Regulation of gene-activation pathways by PIAS proteins in the immune system. Nat Rev Immunol 5 8 (2005) 593-605
210. Guermah M., Malik S., and Roeder R.G. Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1. Mol Cell Biol 18 6 (1998) 3234-3244
211. Ainbinder E., Revach M., Wolstein O., Moshonov S., Diamant N., and Dikstein R. Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB. Mol Cell Biol 22 18 (2002) 6354-6362
212. Yamit-Hezi A., Nir S., Wolstein O., and Dikstein R. Interaction of TAFII105 with selected p65/RelA dimers is associated with activation of subset of NF-kappa B genes. J Biol Chem 275 24 (2000) 18180-18187
213. Yamit-Hezi A., and Dikstein R. TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB. EMBO J 17 17 (1998) 5161-5169
214. Kim T.K., Kim T.H., and Maniatis T. Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-beta enhanceosome in vitro. Proc Natl Acad Sci USA 95 21 (1998) 12191-12196
215. Paal K., Baeuerle P.A., and Schmitz M.L. Basal transcription factors TBP and TFIIB and the viral coactivator E1A 13S bind with distinct affinities and kinetics to the transactivation domain of NF-kappaB p65. Nucl Acids Res 25 5 (1997) 1050-1055
216. Buratowski S. The CTD code. Nat Struct Biol 10 9 (2003) 679-680
217. Saunders A., Core L.J., and Lis J.T. Breaking barriers to transcription elongation. Nat Rev Mol Cell Biol 7 8 (2006) 557-567
218. Eissenberg J.C., and Shilatifard A. Leaving a mark: the many footprints of the elongating RNA polymerase II. Curr Opin Genet Dev 16 2 (2006) 184-190
219. Peterlin B.M., and Price D.H. Controlling the Elongation Phase of Transcription with P-TEFb. Molecular Cell 23 3 (2006) 297-305
220. Conaway R.C., Sato S., Tomomori-Sato C., Yao T., and Conaway J.W. The mammalian mediator complex and its role in transcriptional regulation. Trends Biochem Sci 30 5 (2005) 250-255
221. Naar A.M., Beaurang P.A., Zhou S., Abraham S., Solomon W., and Tjian R. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 398 6730 (1999) 828-832
222. Van Lint C., Emiliani S., Ott M., and Verdin E. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J 15 5 (1996) 1112-1120
223. Van Lint C. Role of chromatin in HIV-1 transcriptional regulation. Adv Pharmacol 48 (2000) 121-160
224. Brettingham-Moore K.H., Rao S., Juelich T., Shannon M.F., and Holloway A.F. GM-CSF promoter chromatin remodelling and gene transcription display distinct signal and transcription factor requirements. Nucl Acids Res 33 1 (2005) 225-234
225. Castellano R, Vire B, Pion M, Quivy V, Olive D, Hirsch I, et al. Active transcription of the human FASL/CD95L/TNFSF6 promoter region in T lymphocytes involves chromatin remodelling: role of DNA methylation and protein acetylation suggest distinct mechanisms of transcriptional repression. J Biol Chem 2006.
226. Goriely S., Demonte D., Nizet S., De Wit D., Willems F., Goldman M., et al. Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites. Blood 101 12 (2003) 4894-4902
227. Weinmann A.S., Plevy S.E., and Smale S.T. Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription. Immunity 11 6 (1999) 665-675
228. Weinmann A.S., Mitchell D.M., Sanjabi S., Bradley M.N., Hoffmann A., Liou H.C., et al. Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event. Nat Immunol 2 1 (2001) 51-57
229. Rao S., Gerondakis S., Woltring D., and Shannon M.F. c-Rel is required for chromatin remodeling across the IL-2 gene promoter. J Immunol 170 7 (2003) 3724-3731
230. Shoemaker J., Saraiva M., and O'Garra A. GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells. J Immunol 176 6 (2006) 3470-3479
231. Wang T., Lafuse W.P., and Zwilling B.S. Regulation of Toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J Immunol 165 11 (2000) 6308-6313
232. Deroo B.J., and Archer T.K. Glucocorticoid receptor activation of the I kappa B alpha promoter within chromatin. Mol Biol Cell 12 11 (2001) 3365-3374
233. Lomvardas S., and Thanos D. Opening chromatin. Mol Cell 9 2 (2002) 209-211
234. Cirillo L.A., Lin F.R., Cuesta I., Friedman D., Jarnik M., and Zaret K.S. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell 9 2 (2002) 279-289
235. Blewitt M.E., Vickaryous N.K., Paldi A., Koseki H., and Whitelaw E. Dynamic reprogramming of DNA methylation at an epigenetically sensitive allele in mice. PLoS Genet 2 4 (2006) e49
236. Boyer L.A., Plath K., Zeitlinger J., Brambrink T., Medeiros L.A., Lee T.I., et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441 (2006) 349-353
237. Loh Y.H., Wu Q., Chew J.L., Vega V.B., Zhang W., Chen X., et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 38 4 (2006) 431-440
238. Lee T.I., Jenner R.G., Boyer L.A., Guenther M.G., Levine S.S., Kumar R.M., et al. Control of developmental regulators by polycomb in human embryonic stem cells. Cell 125 2 (2006) 301-313
239. Bernstein B.E., Mikkelsen T.S., Xie X., Kamal M., Huebert D.J., Cuff J., et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 2 (2006) 315-326
240. Azuara V., Perry P., Sauer S., Spivakov M., Jorgensen H.F., John R.M., et al. Chromatin signatures of pluripotent cell lines. Nat Cell Biol 8 (2006) 532-538
241. Crook J.M., Dunn N.R., and Colman A. Repressed by a NuRD. Nat Cell Biol 8 3 (2006) 212-214
242. Karp X., and Ambros V. Developmental biology. Encountering microRNAs in cell fate signalling. Science 310 5752 (2005) 1288-1289
243. Raftopoulou M. microRNA signals cell fate. Nat Cell Biol 8 2 (2006) 112
244. Meshorer E, Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol 2006.
245. Meshorer E., Yellajoshula D., George E., Scambler P.J., Brown D.T., and Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev Cell 10 1 (2006) 105-116
246. Meaney M.J., and Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 7 2 (2005) 103-123
247. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl (2003) 245-254
248. Takada T., Yagi Y., Maekita T., Imura M., Nakagawa S., Tsao S.W., et al. Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. Cancer Sci 95 9 (2004) 741-744
249. Suzuki T., and Miyata N. Epigenetic control using natural products and synthetic molecules. Curr Med Chem 13 8 (2006) 935-958
250. Dennis C. Epigenetics and disease: altered states. Nature 421 6924 (2003) 686-688
251. Issa J.P. Age-related epigenetic changes and the immune system. Clin Immunol 109 1 (2003) 103-108
252. Lai S.R., Phipps S.M., Liu L., Andrews L.G., and Tollefsbol T.O. Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems. Front Biosci 10 (2005) 1779-1796
253. Liu L., Wylie R.C., Andrews L.G., and Tollefsbol T.O. Aging, cancer and nutrition: the DNA methylation connection. Mech Ageing Dev 124 10-12 (2003) 989-998
254. Issa J.P., Ahuja N., Toyota M., Bronner M.P., and Brentnall T.A. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61 9 (2001) 3573-3577
255. Ahuja N., Li Q., Mohan A.L., Baylin S.B., and Issa J.P. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 58 23 (1998) 5489-5494
256. Waki T., Tamura G., Sato M., and Motoyama T. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 22 26 (2003) 4128-4133
257. Goldmit M., Ji Y., Skok J., Roldan E., Jung S., Cedar H., et al. Epigenetic ontogeny of the Igk locus during B cell development. Nat Immunol 6 2 (2005) 198-203
258. Reiner S.L. Epigenetic control in the immune response. Hum Mol Genet 14 Spec no 1 (2005) R41-R46
259. Galm O., Herman J.G., and Baylin S.B. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev 20 1 (2006) 1-13
260. Kim J.Y., Siegmund K.D., Tavare S., and Shibata D. Age-related human small intestine methylation: evidence for stem cell niches. BMC Med 3 (2005) 10
261. Glaser R., and Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat Rev Immunol 5 3 (2005) 243-251
262. Hyman S.E. Even chromatin gets the blues. Nat Neurosci 9 4 (2006) 465-466
263. Weaver I.C., Cervoni N., Champagne F.A., D'Alessio A.C., Sharma S., Seckl J.R., et al. Epigenetic programming by maternal behavior. Nat Neurosci 7 8 (2004) 847-854
264. Levenson J.M., and Sweatt J.D. Epigenetic mechanisms in memory formation. Nat Rev Neurosci 6 2 (2005) 108-118
265. Tao Q., and Robertson K.D. Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin Immunol 109 1 (2003) 53-63
266. Maekita T., Nakazawa K., Mihara M., Nakajima T., Yanaoka K., Iguchi M., et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12 3 Pt 1 (2006) 989-995
267. Li H.P., Leu Y.W., and Chang Y.S. Epigenetic changes in virus-associated human cancers. Cell Res 15 4 (2005) 262-271
268. Müller K., Heller H., and Doerfler W. Foreign DNA integration. Genome-wide perturbations of methylation and transcription in the recipient genomes. J Biol Chem 276 17 (2001) 14271-14278
269. Kang G.H., Lee S., Kim W.H., Lee H.W., Kim J.C., Rhyu M.G., et al. Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160 3 (2002) 787-794
270. Dolinoy D.C., Weidman J.R., Waterland R.A., and Jirtle R.L. Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome. Environ Health Perspect 114 4 (2006) 567-572
271. Wolff G.L., Kodell R.L., Moore S.R., and Cooney C.A. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 12 11 (1998) 949-957
272. Waterland R.A., and Jirtle R.L. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol 23 15 (2003) 5293-5300
273. Waterland R.A., and Jirtle R.L. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20 1 (2004) 63-68
274. Aggarwal B.B., and Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71 10 (2006) 1397-1421
275. Myzak M.C., Ho E., and Dashwood R.H. Dietary agents as histone deacetylase inhibitors. Mol Carcinog 45 6 (2006) 443-446
276. Dashwood R.H., Myzak M.C., and Ho E. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?. Carcinogenesis 27 2 (2006) 344-349
277. Crews D., and McLachlan J.A. Epigenetics, evolution, endocrine disruption, health, and disease. Endocrinology 147 6 Suppl (2006) S4-S10
278. Thomassin H., Flavin M., Espinas M.L., and Grange T. Glucocorticoid-induced DNA demethylation and gene memory during development. EMBO J 20 8 (2001) 1974-1983
279. Fujita N., Jaye D.L., Kajita M., Geigerman C., Moreno C.S., and Wade P.A. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113 2 (2003) 207-219
280. Bombail V., Moggs J.G., and Orphanides G. Perturbation of epigenetic status by toxicants. Toxicol Lett 149 1-3 (2004) 51-58
281. Moggs J.G., and Orphanides G. The role of chromatin in molecular mechanisms of toxicity. Toxicol Sci 80 2 (2004) 218-224
282. Sutherland J.E., and Costa M. Epigenetics and the environment. Ann N Y Acad Sci 983 (2003) 151-160
283. Watson R.E., and Goodman J.I. Epigenetics and DNA methylation come of age in toxicology. Toxicol Sci 67 1 (2002) 11-16
284. Grun F., and Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signalling. Endocrinology 147 6 Suppl (2006) S50-S55
285. Anway M.D., and Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors. Endocrinology 147 6 Suppl (2006) S43-S49
286. Ruden D.M., Xiao L., Garfinkel M.D., and Lu X. Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstibesterol on uterine development and cancer. Hum Mol Genet 14 Spec no 1 (2005) R149-R155
287. Anway M.D., Cupp A.S., Uzumcu M., and Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308 5727 (2005) 1466-1469
288. McLachlan J.A., Simpson E., and Martin M. Endocrine disrupters and female reproductive health. Best Pract Res Clin Endocrinol Metab 20 1 (2006) 63-75
289. Queitsch C., Sangster T.A., and Lindquist S. Hsp90 as a capacitor of phenotypic variation. Nature 417 6889 (2002) 618-624
290. Sangster T.A., Queitsch C., and Lindquist S. Hsp90 and chromatin: where is the link?. Cell Cycle 2 3 (2003) 166-168
291. Sangster T.A., Lindquist S., and Queitsch C. Under cover: causes, effects and implications of Hsp90-mediated genetic capacitance. Bioessays 26 4 (2004) 348-362
292. Pigliucci M. Epigenetics is back! Hsp90 and phenotypic variation. Cell Cycle 2 1 (2003) 34-35
293. Pigliucci M. Developmental genetics: buffer zone. Nature 417 6889 (2002) 598-599
294. Vercelli D. Genetics, epigenetics, and the environment: switching, buffering, releasing. J Allergy Clin Immunol 113 3 (2004) 381-386 [quiz 387]
295. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102 30 (2005) 10604-10609
296. Peng B., Hodge D.R., Thomas S.B., Cherry J.M., Munroe D.J., Pompeia C., et al. Epigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells. J Biol Chem 280 6 (2005) 4182-4187
297. Pompeia C., Hodge D.R., Plass C., Wu Y.Z., Marquez V.E., Kelley J.A., et al. Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line. Cancer Res 64 10 (2004) 3465-3473
298. Hodge D.R., Peng B., Cherry J.C., Hurt E.M., Fox S.D., Kelley J.A., et al. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res 65 11 (2005) 4673-4682
299. Croonquist P.A., and Van Ness B. The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype. Oncogene 24 41 (2005) 6269-6280
300. Milutinovic S., Zhuang Q., Niveleau A., and Szyf M. Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. J Biol Chem 278 17 (2003) 14985-14995
301. Armenante F., Merola M., Furia A., and Palmieri M. Repression of the IL-6 gene is associated with hypermethylation. Biochem Biophys Res Commun 258 3 (1999) 644-647
302. Ershler W.B., and Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51 (2000) 245-270
303. Dijsselbloem N., Vanden Berghe W., De Naeyer A., and Haegeman G. Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections: multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol 68 (2004) 1171-1185
304. Balducci L., and Ershler W.B. Cancer and ageing: a nexus at several levels. Nat Rev Cancer 5 8 (2005) 655-662
305. To K.F., Chan M.W., Leung W.K., Ng E.K., Yu J., Bai A.H., et al. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. Br J Cancer 91 7 (2004) 1335-1341
306. Galm O., Yoshikawa H., Esteller M., Osieka R., and Herman J.G. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 101 7 (2003) 2784-2788
307. Lee T.L., Yeh J., Van Waes C., and Chen Z. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas. Mol Cancer Ther 5 1 (2006) 8-19
308. Hodge D.R., Peng B., Pompeia C., Thomas S., Cho E., Clausen P.A., et al. Epigenetic silencing of manganese superoxide dismutase (SOD-2) in KAS 6/1 human multiple myeloma cells increases cell proliferation. Cancer Biol Ther 4 5 (2005)
309. Smith P.C., and Keller E.T. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice. Prostate 48 1 (2001) 47-53
310. Santourlidis S., Warskulat U., Florl A.R., Maas S., Pulte T., Fischer J., et al. Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinoma. Mol Carcinog 32 1 (2001) 36-43
311. Richards E.J. Inherited epigenetic variation-revisiting soft inheritance. Nat Rev Genet 7 5 (2006) 395-401
312. Trouche D., Khochbin S., and Dimitrov S. Chromatin and epigenetics: dynamic organization meets regulated function. Mol Cell 12 2 (2003) 281-286
313. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 16 1 (2002) 6-21
314. Kouskouti A., and Talianidis I. Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO J 24 2 (2005) 347-357
315. Cheng L.C., Tavazoie M., and Doetsch F. Stem cells: from epigenetics to microRNAs. Neuron 46 3 (2005) 363-367
316. Kim V.N., and Nam J.W. Genomics of microRNA. Trends Genet 22 3 (2006) 165-173
317. Andersen A.A., and Panning B. Epigenetic gene regulation by noncoding RNAs. Curr Opin Cell Biol 15 3 (2003) 281-289
318. Mattick J.S. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2 11 (2001) 986-991
319. Frith M.C., Pheasant M., and Mattick J.S. The amazing complexity of the human transcriptome. Eur J Hum Genet 13 8 (2005) 894-897
320. Bernstein E., and Allis C.D. RNA meets chromatin. Genes Dev 19 14 (2005) 1635-1655
321. Mendes Soares L.M., and Valcarcel J. The expanding transcriptome: the genome as the 'book of sand'. EMBO J 25 5 (2006) 923-931
322. Wassenegger M. The role of the RNAi machinery in heterochromatin formation. Cell 122 1 (2005) 13-16
323. Wassenegger M. RNA-directed DNA methylation. Plant Mol Biol 43 2-3 (2000) 203-220
324. Jones D.O., Cowell I.G., and Singh P.B. Mammalian chromodomain proteins: their role in genome organisation and expression. Bioessays 22 2 (2000) 124-137
325. Akhtar A., Zink D., and Becker P.B. Chromodomains are protein-RNA interaction modules. Nature 407 6802 (2000) 405-409
326. Brehm A., Tufteland K.R., Aasland R., and Becker P.B. The many colours of chromodomains. Bioessays 26 2 (2004) 133-140
327. Lanz R.B., McKenna N.J., Onate S.A., Albrecht U., Wong J., Tsai S.Y., et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97 1 (1999) 17-27
328. Bartel D.P., and Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5 5 (2004) 396-400
329. Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., et al. The transcriptional landscape of the mammalian genome. Science 309 5740 (2005) 1559-1563
330. Mattick J.S., and Makunin I.V. Small regulatory RNAs in mammals. Hum Mol Genet 14 Spec no 1 (2005) R121-R132
331. Mattick J.S. The functional genomics of noncoding RNA. Science 309 5740 (2005) 1527-1528
332. Taganov KD, Boldin MP, Chang KJ, Baltimore D, NF-{kappa}B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006.
333. Sood P., Krek A., Zavolan M., Macino G., and Rajewsky N. Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci USA 103 8 (2006) 2746-2751
334. The microRevolution. Nat Genet 38 Suppl 1 (2006) S1
335. Claudio E., Brown K., and Siebenlist U. NF-kappaB guides the survival and differentiation of developing lymphocytes. Cell Death Differ 13 5 (2006) 697-701
336. Siebenlist U., Brown K., and Claudio E. Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol 5 6 (2005) 435-445
337. Fisher A.G. Cellular identity and lineage choice. Nat Rev Immunol 2 12 (2002) 977-982
338. Bottero V., Withoff S., and Verma I.M. NF-kappaB and the regulation of hematopoiesis. Cell Death Differ 13 5 (2006) 785-797
339. Matthias P., and Rolink A.G. Transcriptional networks in developing and mature B cells. Nat Rev Immunol 5 6 (2005) 497-508
340. Messi M., Giacchetto I., Nagata K., Lanzavecchia A., Natoli G., and Sallusto F. Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. Nat Immunol 4 1 (2003) 78-86
341. Kersh E.N., Fitzpatrick D.R., Murali-Krishna K., Shires J., Speck S.H., Boss J.M., et al. Rapid demethylation of the IFN-gamma gene occurs in memory but not naive CD8 T cells. J Immunol 176 7 (2006) 4083-4093
342. Sanders VM. Epigenetic regulation of Th1 and Th2 cell development. Brain Behav Immun 2005. doi:10.1016/j.bbi.2005.08.005.
343. Monticelli S., Ansel K.M., Xiao C., Socci N.D., Krichevsky A.M., Thai T.H., et al. MicroRNA profiling of the murine hematopoietic system. Genome Biol 6 8 (2005) R71
344. Chen C.Z., Li L., Lodish H.F., and Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303 5654 (2004) 83-86
345. Ambros V. The functions of animal microRNAs. Nature 431 7006 (2004) 350-355
346. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123 5 (2005) 819-831
347. Braun T., Carvalho G., Fabre C., Grosjean J., Fenaux P., and Kroemer G. Targeting NF-kappaB in hematologic malignancies. Cell Death Differ 13 5 (2006) 748-758
348. Mann J, Oakley F, Akiboye F, Elsharkawy A, Thorne AW, Mann DA. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ 2006.
349. Oswald F., Liptay S., Adler G., and Schmid R.M. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol 18 4 (1998) 2077-2088
350. Murayama A., Sakura K., Nakama M., Yasuzawa-Tanaka K., Fujita E., Tateishi Y., et al. A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. EMBO J 25 5 (2006) 1081-1092
351. Sen R., and Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47 6 (1986) 921-928
352. Schlissel M.S., and Baltimore D. Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription. Cell 58 5 (1989) 1001-1007
353. Goldmit M., and Bergman Y. Monoallelic gene expression: a repertoire of recurrent themes. Immunol Rev 200 (2004) 197-214
354. Bergman Y., and Cedar H. A stepwise epigenetic process controls immunoglobulin allelic exclusion. Nat Rev Immunol 4 10 (2004) 753-761
355. Lund A.H., and van Lohuizen M. Epigenetics and cancer. Genes Dev 18 19 (2004) 2315-2335
356. Jones P.A. Overview of cancer epigenetics. Semin Hematol 42 3 Suppl 2 (2005) S3-S8
357. Holm T.M., Jackson-Grusby L., Brambrink T., Yamada Y., Rideout III W.M., and Jaenisch R. Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8 4 (2005) 275-285
358. Feinberg A.P., Ohlsson R., and Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 7 1 (2006) 21-33
359. Esteller M. Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 94 2 (2006) 179-183
360. Ropero S., Fraga M.F., Ballestar E., Hamelin R., Yamamoto H., Boix-Chornet M., et al. A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition. Nat Genet 38 5 (2006) 566-569
361. Kirillov A., Kistler B., Mostoslavsky R., Cedar H., Wirth T., and Bergman Y. A role for nuclear NF-kappaB in B-cell-specific demethylation of the Igkappa locus. Nat Genet 13 4 (1996) 435-441
362. Goldmit M., Schlissel M., Cedar H., and Bergman Y. Differential accessibility at the kappa chain locus plays a role in allelic exclusion. EMBO J 21 19 (2002) 5255-5261
363. Inlay M., and Xu Y. Epigenetic regulation of antigen receptor rearrangement. Clin Immunol 109 1 (2003) 29-36
364. Scherer D.C., Brockman J.A., Bendall H.H., Zhang G.M., Ballard D.W., and Oltz E.M. Corepression of RelA and c-rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytes. Immunity 5 6 (1996) 563-574
365. Inlay M.A., Tian H., Lin T., and Xu Y. Important roles for E protein binding sites within the immunoglobulin kappa chain intronic enhancer in activating Vkappa Jkappa rearrangement. J Exp Med 200 9 (2004) 1205-1211
366. Sen R. NF-kappaB and the immunoglobulin kappa gene enhancer. J Exp Med 200 9 (2004) 1099-1102
367. Verkoczy L., Ait-Azzouzene D., Skog P., Martensson A., Lang J., Duong B., et al. A role for nuclear factor kappa B/rel transcription factors in the regulation of the recombinase activator genes. Immunity 22 4 (2005) 519-531
368. Amin R.H., and Schlissel M.S. NF-kappa B comes home. Immunity 22 4 (2005) 401-402
369. Wei C.L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 124 1 (2006) 207-219
370. Cawley S., Bekiranov S., Ng H.H., Kapranov P., Sekinger E.A., Kampa D., et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116 4 (2004) 499-509
371. Mattick J.S. RNA regulation: a new genetics?. Nat Rev Genet 5 4 (2004) 316-323
372. Goodrich J.A., and Kugel J.F. Non-coding-RNA regulators of RNA polymerase II transcription. Nat Rev Mol Cell Biol (2006)
373. Bickel K.S., and Morris D.R. Silencing the transcriptome's dark matter: mechanisms for suppressing translation of intergenic transcripts. Mol Cell 22 3 (2006) 309-316
374. Benoist C., Germain R.N., and Mathis D. A plaidoyer for 'systems immunology'. Immunol Rev 210 (2006) 229-234
375. West A.G., and Fraser P. Remote control of gene transcription. Hum Mol Genet 14 Spec no 1 (2005) R101-R111
376. Zhou G.L., Xin L., Song W., Di L.J., Liu G., Wu X.S., Liu D.P., and Liang C.C. Active chromatin hub of the mouse alpha-globin locus forms in a transcription factory of clustered housekeeping genes. Mol Cell Biol 26 13 (2006) 5096-5105
377. Lieb J.D., and Clarke N.D. Control of transcription through intragenic patterns of nucleosome composition. Cell 123 7 (2005) 1187-1190
378. Ho Y., Elefant F., Liebhaber S.A., and Cooke N.E. Locus control region transcription plays an active role in long-range gene activation. Mol Cell 23 3 (2006) 365-375
379. Forrester W.C., Fernandez L.A., and Grosschedl R. Nuclear matrix attachment regions antagonize methylation-dependent repression of long-range enhancer-promoter interactions. Genes Dev 13 22 (1999) 3003-3014
380. Dobreva G., Dambacher J., and Grosschedl R. SUMO modification of a novel MAR-binding protein, SATB2, modulates immunoglobulin mu gene expression. Genes Dev 17 24 (2003) 3048-3061
381. Lorincz M.C., Dickerson D.R., Schmitt M., and Groudine M. Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat Struct Mol Biol 11 11 (2004) 1068-1075
382. Zhou G.L., Xin L., Song W., Di L.J., Liu G., Wu X.S., Liu D.P., and Liang C.C. Active chromatin hub of the mouse alpha-globin locus forms in a transcription factory of clustered housekeeping genes. Mol Cell Biol 26 13 (2006) 5096-5105
383. Palstra R.J., Tolhuis B., Splinter E., Nijmeijer R., Grosveld F., and de Laat W. The beta-globin nuclear compartment in development and erythroid differentiation. Nat Genet 35 2 (2003) 190-194
384. Splinter E., Grosveld F., and de Laat W. 3C technology: analyzing the spatial organization of genomic loci in vivo. Meth Enzymol 375 (2004) 493-507
385. Patrinos G.P., de Krom M., de Boer E., Langeveld A., Imam A.M., Strouboulis J., et al. Multiple interactions between regulatory regions are required to stabilize an active chromatin hub. Genes Dev 18 12 (2004) 1495-1509
386. Bolland D.J., Wood A.L., Johnston C.M., Bunting S.F., Morgan G., Chakalova L., et al. Antisense intergenic transcription in V(D)J recombination. Nat Immunol 5 6 (2004) 630-637
387. Osborne C.S., Chakalova L., Brown K.E., Carter D., Horton A., Debrand E., et al. Active genes dynamically colocalize to shared sites of ongoing transcription. Nat Genet 36 10 (2004) 1065-1071
388. Chakalova L., Carter D., and Fraser P. RNA fluorescence in situ hybridization tagging and recovery of associated proteins to analyze in vivo chromatin interactions. Meth Enzymol 375 (2004) 479-493
389. Frigola J., Song J., Stirzaker C., Hinshelwood R.A., Peinado M.A., and Clark S.J. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet 38 5 (2006) 540-549
390. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 441 7092 (2006) 431-436
391. Ozdag H., Teschendorff A.E., Ahmed A.A., Hyland S.J., Blenkiron C., Bobrow L., et al. Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics 7 (2006) 90
392. Dunn K.L., Espino P.S., Drobic B., He S., and Davie J.R. The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol 83 1 (2005) 1-14
393. Espino P.S., Li L., He S., Yu J., and Davie J.R. Chromatin modification of the trefoil factor 1 gene in human breast cancer cells by the Ras/mitogen-activated protein kinase pathway. Cancer Res 66 9 (2006) 4610-4616
394. Garcia-Pedrero JM, Kiskinis E, Parker MG, Belandia B. The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells. J Biol Chem 2006.
395. Kiskinis E, Garcia-Pedrero JM, Villaronga MA, Parker MG, Belandia B. Identification of BAF57 mutations in human breast cancer cell lines. Breast Cancer Res Treat 2006.
396. Kleer C.G., Cao Q., Varambally S., Shen R., Ota I., Tomlins S.A., et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 100 20 (2003) 11606-11611
397. Bachmann I.M., Halvorsen O.J., Collett K., Stefansson I.M., Straume O., Haukaas S.A., et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 24 2 (2006) 268-273
398. Kim J.H., Kim B., Cai L., Choi H.J., Ohgi K.A., Tran C., et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and beta-catenin complexes. Nature 434 7035 (2005) 921-926
399. Kim J.H., Choi H.J., Kim B., Kim M.H., Lee J.M., Kim I.S., et al. Roles of sumoylation of a reptin chromatin-remodelling complex in cancer metastasis. Nat Cell Biol 8 6 (2006) 631-639
400. Schmidt C., Peng B., Li Z., Sclabas G.M., Fujioka S., Niu J., et al. Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation. Mol Cell 12 5 (2003) 1287-1300
401. Li C.C., Ramirez-Carrozzi V.R., and Smale S.T. Pursuing gene regulation 'logic' via RNA interference and chromatin immunoprecipitation. Nat Immunol 7 7 (2006) 692-697
402. Verdin E., Paras Jr. P., and Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J 12 8 (1993) 3249-3259
403. Armenante F., Merola M., Furia A., Tovey M., and Palmieri M. Interleukin-6 repression is associated with a distinctive chromatin structure of the gene. Nucl Acids Res 27 22 (1999) 4483-4490
404. Ngo V.N., Davis R.E., Lamy L., Yu X., Zhao H., Lenz G., et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441 7089 (2006) 106-110
405. Matsuyama M., and Yoshimura R. Prospects of antisense oligodeoxynucleotides to alleviate renal ischaemia-reperfusion injury. Expert Opin Biol Ther 4 12 (2004) 1931-1937
406. Chen Z., Lu L., Zhang H., Dean N.M., Fung J.J., and Qian S. Administration of antisense oligodeoxyribonucleotides targeting NF-kappaB prolongs allograft survival via suppression of cytotoxicity. Microsurgery 23 5 (2003) 494-497
407. Tomita N., Azuma H., Kaneda Y., Ogihara T., and Morishita R. Application of decoy oligodeoxynucleotides-based approach to renal diseases. Curr Drug Targets 5 8 (2004) 717-733
408. Tomita N., Ogihara T., and Morishita R. Transcription factors as molecular targets: molecular mechanisms of decoy ODN and their design. Curr Drug Targets 4 8 (2003) 603-608
409. Aggarwal B.B., Ichikawa H., Garodia P., Weerasinghe P., Sethi G., Bhatt I.D., et al. From traditional ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets 10 1 (2006) 87-118
410. Haefner B. NF-kappa B: arresting a major culprit in cancer. Drug Discov Today 7 12 (2002) 653-663
411. Luo J.L., Kamata H., and Karin M. IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy. J Clin Invest 115 10 (2005) 2625-2632
412. O'Neill L.A. Targeting signal transduction as a strategy to treat inflammatory diseases. Nat Rev Drug Discov 5 7 (2006) 549-563
413. Nakanishi C., and Toi M. Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs. Nat Rev Cancer 5 4 (2005) 297-309
414. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2 5 (2002) 364-371
415. Ogata H., and Hibi T. Cytokine and anti-cytokine therapies for inflammatory bowel disease. Curr Pharm Des 9 14 (2003) 1107-1113
416. Carlsen H., Moskaug J.O., Fromm S.H., and Blomhoff R. In vivo imaging of NF-kappa B activity. J Immunol 168 3 (2002) 1441-1446
417. Gross S., and Piwnica-Worms D. Real-time imaging of ligand-induced IKK activation in intact cells and in living mice. Nat Meth 2 8 (2005) 607-614